Headache Inducing Effect of NN414 in Migraine Patients
Not Applicable
Recruiting
- Conditions
- Headache, Migraine
- Interventions
- Drug: NN414Drug: Saline
- Registration Number
- NCT04744129
- Lead Sponsor
- Danish Headache Center
- Brief Summary
To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
- Migraine patients of both sexes.
- 18-60 years.
- 50-100 kg.
- Women of childbearing potential must use adequate contraception.
Exclusion Criteria
- Headache less than 48 hours before the tests start
- Daily consumption of drugs of any kind other than oral contraceptives
- Pregnant or nursing women.
- Cardiovascular disease of any kind, including cerebrovascular diseases.
- Diabetes mellitus and other endocrinologic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description NN414 NN414 To investigate the role of NN414 compared with placebo in migraine patients. Saline Saline To investigate the role of NN414 compared with placebo in migraine patients.
- Primary Outcome Measures
Name Time Method Occurrence and change of migraine attack Before (-10 min) and after infusion (+2 hours) of NN414 compared with before and after infusion of saline Occurrence of migraine according to international criteria
- Secondary Outcome Measures
Name Time Method Occurrence and change of headache Before (-10 min) and after infusion (+2 hours) of NN414 compared with before and after infusion of saline Occurrence of headache measured by numerical rating scale (NRS)
Change in cerebral hemodynamic Before (-10 min) and after infusion (+2 hours) of NN414 compared with before and after infusion of saline Change on velocity of media cerebri artery.
Change of diameter of the artery Before (-10 min) and after infusion (+2 hours) of NN414 compared with before and after infusion of saline Change of diameter of superficial temporal artery and radial artery. The diameter will be measured by millimeter (mm).
Trial Locations
- Locations (1)
Danish Headache Center
🇩🇰Copenhagen, Capital Region, Denmark